Enlivex Ltd. (ENLV)
1.20
+0.05
(+4.35%)
USD |
NASDAQ |
Nov 18, 16:00
1.23
+0.03
(+2.50%)
Pre-Market: 08:29
Enlivex Price : 1.20 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 1.18 | 1.29 | 1.16 | 1.20 | 39670.00 |
| Nov 17, 2026 | 1.15 | 1.18 | 1.11 | 1.15 | 18950.00 |
| Nov 16, 2026 | 1.09 | 1.13 | 1.00 | 1.12 | 65950.00 |
| Nov 13, 2026 | 1.300 | 1.312 | 1.18 | 1.19 | 22312.00 |
| Nov 12, 2026 | 1.25 | 1.338 | 1.19 | 1.245 | 20751.00 |
| Nov 11, 2026 | 1.20 | 1.27 | 1.180 | 1.26 | 41360.00 |
| Nov 10, 2026 | 1.35 | 1.35 | 1.20 | 1.20 | 47130.00 |
| Nov 09, 2026 | 1.28 | 1.410 | 1.28 | 1.37 | 20885.00 |
| Nov 06, 2026 | 1.27 | 1.30 | 1.23 | 1.27 | 18131.00 |
| Nov 05, 2026 | 1.38 | 1.40 | 1.22 | 1.27 | 47036.00 |
| Nov 04, 2026 | 1.44 | 1.46 | 1.37 | 1.39 | 24093.00 |
| Nov 03, 2026 | 1.43 | 1.56 | 1.43 | 1.46 | 37948.00 |
| Nov 02, 2026 | 1.87 | 1.87 | 1.40 | 1.41 | 137601.0 |
| Oct 30, 2026 | 2.47 | 2.47 | 1.730 | 1.78 | 128299.0 |
| Oct 29, 2026 | 2.62 | 2.76 | 2.46 | 2.54 | 49834.00 |
| Oct 28, 2026 | 2.71 | 2.765 | 2.55 | 2.61 | 36324.00 |
| Oct 27, 2026 | 2.56 | 2.89 | 2.215 | 2.70 | 80490.00 |
| Oct 26, 2026 | 2.774 | 2.798 | 2.562 | 2.603 | 26483.00 |
| Oct 23, 2026 | 2.704 | 2.930 | 2.704 | 2.774 | 41187.00 |
| Oct 22, 2026 | 3.138 | 3.278 | 3.075 | 3.187 | 32819.00 |
| Oct 21, 2026 | 3.566 | 3.677 | 3.20 | 3.235 | 46603.00 |
| Oct 20, 2026 | 3.44 | 3.665 | 3.282 | 3.579 | 27970.00 |
| Oct 19, 2026 | 3.379 | 3.638 | 3.08 | 3.318 | 37965.00 |
| Oct 16, 2026 | 3.685 | 3.734 | 3.272 | 3.28 | 29981.00 |
| Oct 15, 2026 | 3.523 | 3.773 | 3.36 | 3.587 | 35020.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Polyrizon Ltd. | 11.03 |
| NovelStem International Corp. | 0.0068 |
| Brainstorm Cell Therapeutics, Inc. | 0.899 |
| Summit Therapeutics, Inc. | 10.50 |
| PeptiDream Inc. | 6.695 |
Price Related Metrics
| PE Ratio | 0.0025 |
| Price to Book Value | 0.0052 |
| Earnings Yield | 40.28K% |
| Market Cap | 20.20M |